[
  {"doc_id":"F2020-AR-C011","type":"Annual Report","date":"2021-03-01","title":"2020 Annual Report","body":"Helios Quantum Computing launched its first scalable superconducting quantum processor prototype in 2020, achieving $8.2 million in revenue and advancing its IP portfolio with key patents focused on quantum-classical hybrid architectures. Risk factors include manufacturing scale-up and export controls. ESG goals focus on clean manufacturing and diversity."},
  {"doc_id":"F2021-AR-C011","type":"Annual Report","date":"2022-02-28","title":"2021 Annual Report","body":"Revenue and margin growth continued with the release of QuantaOS, a hybrid operating system improving quantum-classical workloads. The company strengthened R&D capabilities and expanded international sales, notably in Europe and Asia."},
  {"doc_id":"F2022-AR-C011","type":"Annual Report","date":"2023-02-27","title":"2022 Annual Report","body":"The FDA breakthrough designation for quantum clinical software opened accelerated US market access. Partnerships with national labs enhanced computational chemistry projects. Focus remained on scaling quantum hardware and software production."},
  {"doc_id":"F2023-AR-C011","type":"Annual Report","date":"2024-02-29","title":"2023 Annual Report","body":"Revenue rose amid industry challenges with reputational vigilance and expanded product releases. Strategic government and academic collaborations bolstered positioning."},
  {"doc_id":"F2024-AR-C011","type":"Annual Report","date":"2025-02-28","title":"2024 Annual Report","body":"The company grew with new product certifications and client wins, strengthened IP through new patents, maintained sustainability commitments, and formed the Tri-Forge joint venture with cloud and AI software partners."},
  {"doc_id":"ER-2025-08-C011","type":"Earnings Release","date":"2025-08-19","title":"Q2 2025 Earnings","body":"EPS rose 12% year-over-year with ARR reaching $80 million. Financial guidance was raised amid strong pipeline growth and strategic partnerships."},
  {"doc_id":"JV-2025-02-C011","type":"Joint Venture Announcement","date":"2025-02-10","title":"Tri-Forge Joint Venture","body":"Helios Quantum Computing announced a joint venture with Borealis CloudWorks and QuantumQuill Software, combining quantum hardware, cloud computing, and AI to accelerate industrial applications."},
  {"doc_id":"PAT-2025-05-C011","type":"Patent Filing","date":"2025-05-12","title":"New Quantum Error Correction Patents","body":"Filed five patents outlining novel quantum error correction mechanisms enabling scalable and fault-tolerant quantum computing hardware."},
  {"doc_id":"GRANT-2020-08-C011","type":"Research Grant","date":"2020-08-25","title":"DOE Quantum Research Grant Award","body":"Department of Energy awarded $3 million research grant for quantum algorithm development focusing on computational chemistry and materials science applications."},
  {"doc_id":"USPTO-2021-03-C011","type":"Patent Grant","date":"2021-03-18","title":"Superconducting Qubit Architecture Patent","body":"Patent US10,987,654 granted for breakthrough superconducting qubit architecture enabling scalable quantum processor design with improved coherence times and reduced error rates."},
  {"doc_id":"FUND-2023-02-C011","type":"Funding Document","date":"2023-02-28","title":"Series B Funding Round $35 Million","body":"Series B funding completed raising $35 million led by quantum-focused venture capital firms. Funding supports hardware scaling, software development, and market expansion initiatives."},
  {"doc_id":"FDA-2022-10-C011","type":"FDA Certification","date":"2022-10-10","title":"Quantum Software Simulator FDA Certification","body":"FDA certification achieved for Quantum Sim Suite enabling use in clinical research and pharmaceutical development. Certification covers drug discovery simulations and molecular modeling applications."},
  {"doc_id":"PART-2023-08-C011","type":"Partnership Agreement","date":"2023-08-05","title":"National Labs Quantum Chemistry Partnership","body":"Strategic partnership with national laboratories for quantum computational chemistry research. Collaboration includes joint research projects, shared computing resources, and co-development of quantum algorithms."},
  {"doc_id":"CUST-2024-04-C011","type":"Customer Contract","date":"2024-04-15","title":"PharmaGen Quantum Computing Services","body":"Multi-year contract with PharmaGen for quantum computing services supporting clinical AI and drug discovery applications. Contract value $5 million annually with expansion options."},
  {"doc_id":"TECH-2024-08-C011","type":"Technology Milestone","date":"2024-08-30","title":"100-Qubit Quantum Processor Achievement","body":"Successfully demonstrated stable operation of 100-qubit quantum processor with industry-leading coherence times and gate fidelities. Milestone represents significant advancement in quantum hardware scaling."},
  {"doc_id":"DARPA-2025-04-C011","type":"Government Contract","date":"2025-04-30","title":"DARPA Quantum Defense Applications","body":"$8 million DARPA contract for quantum computing applications in defense and national security. Project focuses on quantum optimization algorithms and secure quantum communication protocols."},
  {"doc_id":"CLOUD-2025-06-C011","type":"Product Launch","date":"2025-06-25","title":"Quantum Cloud Platform Launch","body":"Commercial launch of Quantum Cloud Platform providing quantum computing as a service. Platform offers access to quantum processors, simulation tools, and algorithm development environments."},
  {"doc_id":"RESEARCH-2025-03-C011","type":"Scientific Publication","date":"2025-03-20","title":"Quantum Advantage Research Paper","body":"Published breakthrough research in Nature demonstrating quantum computational advantage for optimization problems. Research validates commercial quantum computing applications and establishes scientific credibility."},
  {"doc_id":"INTEL-2025-07-C011","type":"Partnership Expansion","date":"2025-07-15","title":"Intel Quantum Hardware Collaboration","body":"Expanded partnership with Intel Quantum for quantum processor manufacturing and development. Collaboration provides access to advanced fabrication capabilities and manufacturing expertise."},
  {"doc_id":"MILESTONE-2025-08-C011","type":"Financial Milestone","date":"2025-08-15","title":"$80M Revenue Run-Rate Achievement","body":"Achieved $80 million annual revenue run-rate milestone reflecting strong commercial traction and successful market expansion. Milestone validates business model and growth strategy execution."}
]
